286 related articles for article (PubMed ID: 20398809)
1. B-cell lymphomas with features intermediate between distinct pathologic entities. From pathogenesis to pathology.
Carbone A; Gloghini A; Aiello A; Testi A; Cabras A
Hum Pathol; 2010 May; 41(5):621-31. PubMed ID: 20398809
[TBL] [Abstract][Full Text] [Related]
2. Diffuse large B-cell lymphoma and its variants.
Dominis M; Dzebro S; Gasparov S; Pesut A; Kusec R
Croat Med J; 2002 Oct; 43(5):535-40. PubMed ID: 12402391
[TBL] [Abstract][Full Text] [Related]
3. [R.E.A.L. classification of non-Hodgkin lymphoma from the clinico-oncologic viewpoint].
Meusers P; Brittinger G
Praxis (Bern 1994); 1998 Jun; 87(23):793-800. PubMed ID: 9654985
[TBL] [Abstract][Full Text] [Related]
4. Large B-cell lymphoma with Hodgkin's features.
García JF; Mollejo M; Fraga M; Forteza J; Muniesa JA; Pérez-Guillermo M; Pérez-Seoane C; Rivera T; Ortega P; Piris MA
Histopathology; 2005 Jul; 47(1):101-10. PubMed ID: 15982329
[TBL] [Abstract][Full Text] [Related]
5. Burkitt lymphoma versus diffuse large B-cell lymphoma: a practical approach.
Bellan C; Stefano L; Giulia de F; Rogena EA; Lorenzo L
Hematol Oncol; 2009 Dec; 27(4):182-5. PubMed ID: 19670467
[TBL] [Abstract][Full Text] [Related]
6. Primary cutaneous lymphoproliferative disorders with dual lineage rearrangement.
Kazakov DV; Kutzner H; Palmedo G; Boudova L; Michaelis S; Michal M; Vanecek T; Magro CM; Mukensnabl P; Dummer R; Burg G; Kempf W
Am J Dermatopathol; 2006 Oct; 28(5):399-409. PubMed ID: 17012914
[TBL] [Abstract][Full Text] [Related]
7. MAL expression in lymphoid cells: further evidence for MAL as a distinct molecular marker of primary mediastinal large B-cell lymphomas.
Copie-Bergman C; Plonquet A; Alonso MA; Boulland ML; Marquet J; Divine M; Möller P; Leroy K; Gaulard P
Mod Pathol; 2002 Nov; 15(11):1172-80. PubMed ID: 12429796
[TBL] [Abstract][Full Text] [Related]
8. Transformation of Follicular Lymphoma to a High-Grade B-Cell Lymphoma With MYC and BCL2 Translocations and Overlapping Features of Burkitt Lymphoma and Acute Lymphoblastic Leukemia: A Case Report and Literature Review.
Bischin AM; Dorer R; Aboulafia DM
Clin Med Insights Blood Disord; 2017; 10():1179545X17692544. PubMed ID: 28579851
[TBL] [Abstract][Full Text] [Related]
9. New REAL clinical entities.
Fisher RI; Miller TP; Grogan TM
Cancer J Sci Am; 1998 Jul; 4 Suppl 2():S5-12. PubMed ID: 9672769
[TBL] [Abstract][Full Text] [Related]
10. The new World Health Organization-European Organization for Research and Treatment of Cancer classification for cutaneous lymphomas: a practical marriage of two giants.
Slater DN
Br J Dermatol; 2005 Nov; 153(5):874-80. PubMed ID: 16225594
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathologic findings in high-grade B-cell lymphomas with typical Burkitt morphologic features but lacking the MYC translocation.
Sevilla DW; Gong JZ; Goodman BK; Buckley PJ; Rosoff P; Gockerman JP; Lagoo AS
Am J Clin Pathol; 2007 Dec; 128(6):981-91. PubMed ID: 18024324
[TBL] [Abstract][Full Text] [Related]
12. Expression of Grb2 distinguishes classical Hodgkin lymphomas from primary mediastinal B-cell lymphomas and other diffuse large B-cell lymphomas.
Miles RR; Mankey CC; Seiler CE; Smith LB; Teruya-Feldstein J; Hsi ED; Elenitoba-Johnson KS; Lim MS
Hum Pathol; 2009 Dec; 40(12):1731-7. PubMed ID: 19716163
[TBL] [Abstract][Full Text] [Related]
13. Composite recurrent hodgkin lymphoma and diffuse large B-cell lymphoma: one clone, two faces.
Huang Q; Wilczynski SP; Chang KL; Weiss LM
Am J Clin Pathol; 2006 Aug; 126(2):222-9. PubMed ID: 16891197
[TBL] [Abstract][Full Text] [Related]
14. Non-Hodgkin's lymphoma: the old and the new.
Cabanillas F
Clin Lymphoma Myeloma Leuk; 2011 Jun; 11 Suppl 1():S87-90. PubMed ID: 22035756
[TBL] [Abstract][Full Text] [Related]
15. T-cell-rich B-cell lymphomas. A clinicopathologic study of 19 cases.
Macon WR; Williams ME; Greer JP; Stein RS; Collins RD; Cousar JB
Am J Surg Pathol; 1992 Apr; 16(4):351-63. PubMed ID: 1373580
[TBL] [Abstract][Full Text] [Related]
16. Gray zone lymphomas in pediatric patients.
Liang X; Greffe B; Cook B; Giller R; Graham DK; McGranahan AN; Wang M
Pediatr Dev Pathol; 2011; 14(1):57-63. PubMed ID: 20331368
[TBL] [Abstract][Full Text] [Related]
17. T-cell-rich large B-cell lymphoma. A study of 30 cases, supporting its histologic heterogeneity and lack of clinical distinctiveness.
Krishnan J; Wallberg K; Frizzera G
Am J Surg Pathol; 1994 May; 18(5):455-65. PubMed ID: 8172320
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of the bcl6 and CD10 proteins is associated with increased apoptosis and proliferation in diffuse large B-cell lymphomas.
Bai M; Agnantis NJ; Skyrlas A; Tsanou E; Kamina S; Galani V; Kanavaros P
Mod Pathol; 2003 May; 16(5):471-80. PubMed ID: 12748254
[TBL] [Abstract][Full Text] [Related]
19. Histiocyte-rich B-cell lymphoma. A distinct clinicopathologic entity possibly related to lymphocyte predominant Hodgkin's disease, paragranuloma subtype.
Delabie J; Vandenberghe E; Kennes C; Verhoef G; Foschini MP; Stul M; Cassiman JJ; De Wolf-Peeters C
Am J Surg Pathol; 1992 Jan; 16(1):37-48. PubMed ID: 1728195
[TBL] [Abstract][Full Text] [Related]
20. Serous effusions in malignant lymphomas: a review.
Das DK
Diagn Cytopathol; 2006 May; 34(5):335-47. PubMed ID: 16604559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
